XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of fair value measurements, recurring
The following table presents the Company’s liabilities that are measured at fair value on a recurring basis and the level within the fair value hierarchy (in thousands):
March 31, December 31,
Level 1Level 2Level 32022Level 1Level 2Level 32021
Contingent earnout consideration$— $— $702 $702 $— $— $608 $608 
Contingent convertible notes$— $— $14,050 $14,050 $— $— $— $— 
Total $— $— $14,752 $14,752 $— $— $608 $608 
Schedule of valuation techniques
The key inputs into the Monte Carlo simulation used to estimate the fair value the earn-out provision were as follows:
March 31, 2022December 31, 2021
Risk-free interest rate2.45%1.02%
Expected volatility90.0%90.0%
Term until liquidation (years)3.133.38
Stock price$1.26$1.13
Discount rate7.86%6.71%
The key inputs into the Monte Carlo simulation used to estimate the fair value the Contingent Convertible Notes Payable as of March 31, 2022 were as follows:
March 31, 2022
Risk-free interest rate1.63%
Expected volatility90.0%
Term until liquidation (years)0.84
Stock price$1.26
Discount rate7.2%
Schedule of fair value, liabilities measured on recurring basis, unobservable input reconciliation
The following table presents the changes in the assets and liabilities measured at fair value on a recurring basis classified as Level 3 (in thousands):
Three months ended March 31,
20222021
Balance - beginning of period$608 $1,416 
   Transfer of contingent convertible notes payable from Level 210,000 — 
   Increase in principle of convertible notes for paid-in-kind interest158 — 
Change in fair value of contingent earnout consideration94 (335)
Change in fair value of contingent convertible notes payable3,892 — 
Balance - end of period$14,752 $1,081